Skip to main content

Expanding patient access through flexible specimen collection models

Case study

Expanding patient access through flexible specimen collection models

How Quest Diagnostics BioPharma Services helped a rare disease sponsor improve patient access and participation across a geographically dispersed clinical trial population.
Phlebotomist drawing a sample from a patient

A patient-centric approach to expediting and simplifying clinical trials

This external real-world rare disease case study demonstrates how Quest Diagnostics BioPharma Services resolved clinical site travel barriers for a geographically dispersed patient population. By implementing a 3-tier hybrid specimen collection model (Clinical Sites, local Quest Patient Service Centers, and ExamOne in-home mobile phlebotomy), approximately 16% of collections were completed outside traditional clinical sites (14.29% at PSCs and 1.86% via mobile phlebotomy). This solution reduced patient burden, protected trial enrollment timelines, and ensured protocol compliance through database lock.

Equip your organization with the knowledge to optimize your clinical trial strategies. Download the case study today and discover how Quest Diagnostics can support your success in decentralized trials.

Advance your trials: essential strategies for DCT success

94

* indicates required